Flurbiprofen
- Generic Name
- Flurbiprofen
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H13FO2
- CAS Number
- 5104-49-4
- Unique Ingredient Identifier
- 5GRO578KLP
- Background
Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen may also be used topically prior to ocular surgery to prevent or red...
- Indication
Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be use...
- Associated Conditions
- Ankylosing Spondylitis (AS), Back Pain, Acute, Chronic Back Pain, Menstrual Distress (Dysmenorrhea), Muscle Spasms, Non-Articular Rheumatic Muscle Spasms, Osteoarthritis (OA), Pain, Pain, Inflammatory, Post Traumatic Pain, Postoperative pain, Rheumatoid Arthritis, Spinal pain
- Associated Therapies
- -
CYP2C9 Activity Evaluated With a Simple Finger Prick
- Conditions
- Interventions
- First Posted Date
- 2009-12-04
- Last Posted Date
- 2011-01-11
- Lead Sponsor
- University Hospital, Geneva
- Target Recruit Count
- 10
- Registration Number
- NCT01026714
- Locations
- 🇨🇭
University Hospitals, Geneva 14, Switzerland
Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation
- First Posted Date
- 2009-08-24
- Last Posted Date
- 2018-01-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 87
- Registration Number
- NCT00964106
- Locations
- 🇰🇷
GSK Investigational Site, Seoul, Korea, Republic of
Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs
- First Posted Date
- 2009-06-15
- Last Posted Date
- 2010-11-03
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 24
- Registration Number
- NCT00920088
- Locations
- 🇺🇸
GSK Investigational Site, Baltimore, Maryland, United States
Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects
- Conditions
- Interventions
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2017-09-11
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 23
- Registration Number
- NCT00615212
- Locations
- 🇺🇸
GSK Investigational Site, Buffalo, New York, United States
Local Flurbiprofen to Treat Pain Following Wisdom Tooth Extraction
- Conditions
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 100
- Registration Number
- NCT00001724
- Locations
- 🇺🇸
National Institute of Dental And Craniofacial Research (NIDCR), Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.